Stock NVG NASS VALLEY GATEWAY LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nass Valley Gateway Ltd.

Equities

NVG

CA6315202029

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 07:46:21 21/05/2024 pm IST 		5-day change 1st Jan Change
0.04 CAD +100.00% Intraday chart for Nass Valley Gateway Ltd. -27.27% -11.11%
2023 Nass Valley Gateway Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Nass Valley Gateway Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 18.77 61 28.15 14.08
Enterprise Value (EV) 1 18.75 60.18 28.1 15.39
P/E ratio -5.55 x -19.3 x -6.38 x -4.76 x
Yield - - - -
Capitalization / Revenue - 3,80,29,04,495 x 50,03,45,631 x 74,25,61,135 x
EV / Revenue - 3,75,13,54,841 x 49,93,29,530 x 81,17,16,584 x
EV / EBITDA - - - -
EV / FCF 3,10,11,582 x 2,66,60,436 x 2,59,18,445 x 1,53,67,715 x
FCF Yield 0% 0% 0% 0%
Price to Book -3.63 x -7.6 x -2.26 x -0.94 x
Nbr of stocks (in thousands) 3,12,833 3,12,833 3,12,833 3,12,833
Reference price 2 0.0600 0.1950 0.0900 0.0450
Announcement Date 16/07/20 28/06/21 02/05/22 20/10/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022
Net sales - - 0.016 0.0563 0.019
EBITDA 1 -0.0657 - - - -
EBIT 1 -0.0896 -0.6625 -2.586 -4.101 -1.521
Operating Margin - - -16,119.71% -7,287.7% -8,021.29%
Earnings before Tax (EBT) 1 -0.0961 -2.158 -2.895 -4.294 -2.835
Net income 1 -2.165 -3.305 -3.162 -4.414 -2.96
Net margin - - -19,709.24% -7,844.39% -15,615.32%
EPS 2 -0.007732 -0.0108 -0.0101 -0.0141 -0.009463
Free Cash Flow - 0.6047 2.257 1.084 1.001
FCF margin - - 14,070.87% 1,926.54% 5,281.96%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 16/07/20 16/07/20 28/06/21 02/05/22 20/10/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt 1 - - - - 1.31
Net Cash position 1 0 0.02 0.83 0.06 -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 0.6 2.26 1.08 1
ROE (net income / shareholders' equity) - 48% 43.9% 41.9% 20.1%
ROA (Net income/ Total Assets) - -53.3% -167% -201% -160%
Assets 1 - 6.201 1.891 2.195 1.851
Book Value Per Share 2 -0.0100 -0.0200 -0.0300 -0.0400 -0.0500
Cash Flow per Share 2 0 0 0 0 0
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 16/07/20 16/07/20 28/06/21 02/05/22 20/10/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
NASS VALLEY GATEWAY LTD. Stock Nass Valley Gateway Ltd.
-11.11% 48.8L
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.31% 619.29Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.99% 447.8Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+6.39% 329.47Cr
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-13.10% 311.62Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-4.17% 249.56Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+45.47% 193.95Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-9.11% 168.48Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-2.09% 163.72Cr
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.50% 156.14Cr
Alternative Medicine
  1. Stock Market
  2. Equities
  3. NVG Stock
  4. Financials Nass Valley Gateway Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW